1. Learnings for Health Economics from the Early Stages of the COVID-19 Pandemic

   • Anthony J. Hatswell

   Editorial Open access 10 April 2020 Pages: 203 - 205

2. Group Testing for SARS-CoV-2: Forward to the Past?

   • Koen B. Pouwels
   • Laurence S. J. Roope
   • Philip M. Clarke

   Commentary Open access 28 April 2020 Pages: 207 - 210

3. A Systematic Review of Model-Based Economic Evaluations of Treatments for Venous Leg Ulcers

   • Ashley Layer
   • Emma McManus
   • N. J. Levell

   Systematic Review Open access 27 May 2019 Pages: 211 - 222

   

4. Managing Uncertainties Due to Limited Evidence in Economic Evaluations of Novel Anti-Tuberculosis Regimens: A Systematic Review

   • T. I. Armina Padmasawitri
   • Sarah Maria Saragih
   • Anke M. Hövels

   Systematic Review Open access 11 July 2019 Pages: 223 - 233

   

5. Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong

   • Herbert H. Loong
   • Carlos K. H. Wong
   • Seng Chuen Tan

   Original Research Article Open access 17 September 2019 Pages: 235 - 247

   

6. Cost of Delivering Secondary Healthcare Through the Public Sector in India

   • Shankar Prinja
   • Akashdeep Singh Chauhan
   • Thiagarajan Sundararaman

   Original Research Article Open access 29 August 2019 Pages: 249 - 261

   

7. Touch for Health: Use of Pavlovian Processes with Physical Touch as a Means to Improve Menstrual Hygiene Management Initiatives, Measured by Willingness to Pay

   • Siobhan K. Yilmaz
   • Alok K. Bohara
   • Soumi Roy Chowdhury

   Original Research Article Open access 23 July 2019 Pages: 263 - 276

   

8. Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus

   • Margarita Capel
   • Andreea Ciudin
   • Itziar Oyagüez

   Original Research Article Open access 23 July 2019 Pages: 277 - 286

   

9. Health Technology Assessment of Drugs in Ireland: An Analysis of Timelines

   • Emma Connolly
   • Helen O’Donnell
   • Michael Barry

   Original Research Article Open access 17 September 2019 Pages: 287 - 296

   

10. Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts

    • D. Coyle
    • Pierre J. A. Villeneuve

    Original Research Article Open access 27 September 2019 Pages: 297 - 305

    

11. Ticagrelor Removal by CytoSorb^® in Patients Requiring Emergent or Urgent Cardiac Surgery: A UK-Based Cost-Utility Analysis

    • Mehdi Javanbakht
    • Miranda Trevor
    • Eric Mortensen

    Original Research Article Open access 16 October 2019 Pages: 307 - 319

    

12. Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands

    • Judith J. Gout-Zwart
    • Lisa A. de Jong
    • Maarten J. Postma

    Original Research Article Open access 18 September 2019 Pages: 321 - 330

    

13. Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India

    • Suhaj Abdulsalim
    • Mazhuvancherry Kesavan Unnikrishnan
    • Abubakr A. Alfadl

    Original Research Article Open access 31 July 2019 Pages: 331 - 342

    

14. Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete Resection

    • Rachael Batteson
    • Rose Hart
    • Adenike Amadi

    Original Research Article Open access 05 October 2019 Pages: 343 - 351

    

15. The Costs of Industry-Sponsored Drug Trials in Canada

    • Dat T. Tran
    • Ilke Akpinar
    • Philip Jacobs

    Original Research Article Open access 10 July 2019 Pages: 353 - 359

    

16. A Nationwide Study of Prevalence Rates and Characteristics of 199 Chronic Conditions in Denmark

    • Michael Falk Hvidberg
    • Soeren Paaske Johnsen
    • Lars Ehlers

    Original Research Article Open access 24 July 2019 Pages: 361 - 380

    

17. Treatment Patterns and Costs Associated with Stage IV Non-Small Cell Lung Cancer in a Mexican Population: A Chart Review

    • Jorge Arturo Alatorre
    • Saúl Campos-Gómez
    • Jimena María Iglesias-Chiesa

    Original Research Article Open access 27 August 2019 Pages: 381 - 388

    

18. Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program

    • Christine Leopold
    • Carina Araujo-Lane
    • Anita K. Wagner

    Research Letter Open access 19 July 2019 Pages: 389 - 392